23/01/2026
甲狀腺疾病經常被誤診，並非因其罕見，而是因其複雜性。
全球範圍內，甲狀腺功能減退與亢進常常會因症狀重疊而被漏診；然而在高收入國家的女性甲狀腺癌病例中，估計有高達50-90%被過度診斷。
2013至2017年間，全球有逾170萬例甲狀腺癌診斷可能屬於過度診斷。儘管確診率攀升，死亡率卻基本持平，凸顯單次檢測與倉促臨床決策的潛在風險。
全面的评估、持续的监测和专家的医疗意见有助于获得更好的治疗效果。
Medix取得的成果：
* 18.5% 修正診斷
* 54% 調整或優化治療
* 27 % 避免不必要的治療、醫療程序或手術
-------------------------------------------------------------------
Thyroid disorders are often misunderstood, not because they’re rare, but because they’re complex.
Globally, hypo- and hyperthyroidism are frequently missed due to overlapping symptoms, while up to 50–90% of thyroid cancers in women in high-income countries are estimated to be over-diagnosed.
Between 2013–2017, over 1.7 million thyroid cancer diagnoses worldwide may represent overdiagnosis. Despite rising diagnoses, mortality has remained largely unchanged, underscoring the risks of one-time testing and rushed clinical decisions.
Better outcomes come from integrated review, longitudinal follow-up, and informed opinions.
Medix outcomes achieved:
* Change in diagnosis: 18.5 %
* Change or optimization of treatment: 54%
* Avoidance of unnecessary treatments, procedures, or surgeries: 27%
